Literature DB >> 21506151

Instability of syllable repetition in Parkinson's disease--influence of levodopa and deep brain stimulation.

Sabine Skodda1, Andrea Flasskamp, Uwe Schlegel.   

Abstract

The aim of this study was to test the hypothesis of a fundamental impairment of vocal pace performance in Parkinson's disease (PD) based on a syllable repetition paradigm and the influence of levodopa and deep brain stimulation of the subthalamic nucleus (STN-DBS). Twenty-two PD patients under stable dopaminergic medication, 14 patients with STN-DBS, and 30 controls were tested. Participants had to repeat the syllable /pa/ in a steady pace. Percental coefficient of variance (COV) of interval length was measured for the description of pace stability. Patients were tested in the OFF state and again in the ON state after levodopa administration or ongoing STN-DBS. COV was elevated in both PD subgroups. COV was not influenced by levodopa administration but showed a further deterioration under STN-DBS. The impaired syllable repetition capacity shows similarities to the patterns of more complex speech rhythm abnormalities in PD and therefore might share the same pathophysiology.
Copyright © 2010 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21506151     DOI: 10.1002/mds.23439

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  13 in total

1.  Instability of syllable repetition in progressive supranuclear palsy.

Authors:  Sabine Skodda; Wenke Grönheit; Uwe Schlegel
Journal:  J Neural Transm (Vienna)       Date:  2011-11-08       Impact factor: 3.575

Review 2.  Behavioral and neurophysiological correlates of striatal dopamine depletion: a rodent model of Parkinson's disease.

Authors:  Emily K Plowman; Jeffrey A Kleim
Journal:  J Commun Disord       Date:  2011-04-30       Impact factor: 2.288

3.  Speech-based characterization of dopamine replacement therapy in people with Parkinson's disease.

Authors:  R Norel; C Agurto; S Heisig; J J Rice; H Zhang; R Ostrand; P W Wacnik; B K Ho; V L Ramos; G A Cecchi
Journal:  NPJ Parkinsons Dis       Date:  2020-06-12

Review 4.  Speech disorders in Parkinson's disease: early diagnostics and effects of medication and brain stimulation.

Authors:  L Brabenec; J Mekyska; Z Galaz; Irena Rektorova
Journal:  J Neural Transm (Vienna)       Date:  2017-01-18       Impact factor: 3.575

5.  Effect of Levodopa on Speech Dysfluency in Parkinson's Disease.

Authors:  Hannah Im; Scott Adams; Anita Abeyesekera; Marcus Pieterman; Greydon Gilmore; Mandar Jog
Journal:  Mov Disord Clin Pract       Date:  2018-12-30

6.  Comparative analysis of speech impairment and upper limb motor dysfunction in Parkinson's disease.

Authors:  Jan Rusz; Tereza Tykalová; Radim Krupička; Kateřina Zárubová; Michal Novotný; Robert Jech; Zoltán Szabó; Evžen Růžička
Journal:  J Neural Transm (Vienna)       Date:  2016-12-08       Impact factor: 3.575

7.  Acoustic Analysis of PD Speech.

Authors:  Karen Chenausky; Joel Macauslan; Richard Goldhor
Journal:  Parkinsons Dis       Date:  2011-10-03

8.  Effect of deep brain stimulation on speech performance in Parkinson's disease.

Authors:  Sabine Skodda
Journal:  Parkinsons Dis       Date:  2012-11-21

9.  The Feasibility of Using Acoustic Markers of Speech for Optimizing Patient Outcomes during Randomized Amplitude Variation in Deep Brain Stimulation: A Proof of Principle Methods Study.

Authors:  Adam P Vogel; Hugh J McDermott; Thushara Perera; Mary Jones; Richard Peppard; Colette M McKay
Journal:  Front Bioeng Biotechnol       Date:  2015-07-14

10.  Automatic Evaluation of Speech Rhythm Instability and Acceleration in Dysarthrias Associated with Basal Ganglia Dysfunction.

Authors:  Jan Rusz; Jan Hlavnička; Roman Čmejla; Evžen Růžička
Journal:  Front Bioeng Biotechnol       Date:  2015-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.